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Several effects of androgens on LNCaP-FGC prostate tumor cells showed a biphasic pat- 
tern. Stimulation of growth and inhibition of secretion of prostatic acid phosphatase (PAP) 
was observed at low androgen concentrations (below 1 nM of the synthetic androgen 
R1881), and inhibition of growth and stimulation of PAP secretion was observed at higher 
concentrations. In contrast, prostate specific antigen (PSA) secretion did not show this 
biphasic response pattern. Comparable effects were found for two sublines of the LNCaP- 
FGC cells: an early (passage 20, androgen-dependent) and relatively late (passage 70, 
androgen-sensitive) passage of the cells. Culturing of both sublines in the presence of a high 
concentration of androgens (10 nM R1881) resulted initially in a decrease in growth rate, 
but the cells started to proliferate within 3 weeks. These cells became less sensitive to 
androgens, lost their biphasic response pattern, and showed reduced androgen receptor 
levels. Three weeks after removal of the excess of androgens, the passage 70 cells regained 
a biphasic growth response to androgens. Culture in medium without steroids but with EGF 
resulted in a decrease of both androgen sensitivity and androgen receptor level. 
In conclusion, rapid changes of the androgen sensitivity and receptor level of the 
LNCaP cells occurred under the influence of culture conditions. These changes were partly 
reversible and, therefore, were most likely due to adaptation of the cells. 
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INTRODUCTION 
The prostate gland is dependent on androgens for the maintenance of its normal 
growth and functional integrity. In addition, prostatic tumors are initially androgen- 
responsive, and decrease in size in response to androgen ablation or anti-androgen 
therapy. The extent and duration of the response is variable, and ultimately, prostate 
cancer relapses to an androgen-independent state. The molecular mechanism of this 
loss of growth control by androgens is poorly understood [ 11. 
Only a few permanent growing human prostate cell lines are available for study 
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of prostatic tumors in vitro [2]. Among them, only the LNCaP (lymph node carcinoma 
of the prostate) cell line [3] shows androgen dependent growth. LNCaP cells contain 
considerable amounts of androgen receptors, which are involved in growth regulation 
[3,4] and in secretion of prostatic acid phosphatase (PAP) and prostate-specific an- 
tigen (PSA) [5,6]. The androgen receptor of the LNCaP cells has an unusual broad 
specificity for other steroids such as progestins and estradiol [7-91, and some anti- 
androgens do not inhibit, but stimulate cell growth [lo-131. It has been shown that 
a point mutation in the steroid binding domain of the androgen receptor in LNCaP 
cells is responsible for this phenomenon [ 14,151. No other sex-steroid receptors could 
be detected in LNCaP cells [4,7]. 
For the growth response of LNCaP cells to androgens, a characteristic biphasic 
effect has been observed: increased growth rate at low androgen concentrations, and 
no effect or even cell loss at higher concentrations. The higher concentrations used in 
these studies were in the range of 1-10 nM of the natural ligand dihydrotestosterone 
or the synthetic androgen R1881 [7,16]. Effects of steroids at these concentrations are 
mediated by androgen receptors, and non-specific, toxic effects of steroids are gen- 
erally minimal. A biphasic pattern with opposite direction was shown for apolipopro- 
tein-D secretion (i.e., higher secretion correlates with lower growth rate) [ 171, and for 
the secretion of PAP [ 181. The growth response to la,25-dihydroxyvitamin D, also 
showed biphasic characteristics [ 191. 
In this report, we describe the effects of culturing LNCaP cells under different 
conditions for several weeks, on growth, PAP/PSA secretion, and androgen receptor 
levels. Two sublines of the LNCaP-FGC cell line with different levels of androgen 
receptors and degrees of androgen dependency have been used. We show that rapid 
changes occur with respect to androgen sensitivity and receptor concentration. In 
addition, we show that biphasic response to increasing steroid concentrations is a 
reversible phenomenon that appears and disappears within a few weeks, depending on 
culture conditions. 
MATERIALS AND METHODS 
Materials 
The synthetic androgen R188 1 (methyltrienolone, 17P-Hydroxy- 17a-methyl- 
estra-4,9,11-trien-3-one) and labeled R1881 ([ 17a-Me-3H]-methyltrienolone; 87 Cii 
mmol) were purchased from New England Nuclear (Boston, MA). Epidermal growth 
factor (EGF) from mouse submaxillary gland was obtained from Sigma (St. Louis, 
MO), and fetal calf serum (FCS) from Hyclone (Logan, UT). 
Cell Culture 
The LNCaP-FGC cell line used in the present study was a gift of Dr. Horosze- 
wicz (Buffalo, NY), and was identical with the cell line present at the American Type 
Culture Collection. Two different sublines were used: the parental LNCaP-FGC line, 
cultured for 2-3 passages (subline L20; passage number 20 from the original begin- 
ning cultures of Dr. Horoszewicz), and cells which were maintained in our laboratory 
(subline L70). The L70 cells were obtained from the L20 cells after 1 year culture 
(replating once weekly, in total 50 times) in complete medium containing 7.5% fetal 
calf serum [8]. 
Cells were cultured in RPMI-1640 medium (Gibco, Grand Island, NY) supple- 
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TABLE I. Effects of Different Culture Conditions on the Concentration of Androgen ReceDtors 
Cell type 
L20-Andr 
L20-EGF 
L70-Andr 
L7O- Andr-FCS 
L70-EGF-FCS 
L20-FCS 
L70-FCS 
L7O-EGF 
Culture condition 
5 weeks FCS medium 
5 weeks 10 nM R1881 
5 weeks 1 nM EGF 
5 weeks FCS medium 
5 weeks 10 nM R1881 
5 weeks 1 nM EGF 
5 weeks 10 nM R1881 and 3 weeks FCS medium 
5 weeks 1 nM EGF and 3 weeks FCS medium 
Receptors 
(fmol/mg protein) 
441  * 32 
318 * 35 
83 * 20 
1619 ? 22 
612 * 4 
328 2 8 
862 2 28 
1513 * 3 
Androgen receptor levels in femtomoles of R188 1 bound per milligram of protein in nuclear extracts were 
determined as described in Materials and Methods. Data are expressed as means & SD of three deter- 
minations. Culture media contain either 5% FCS-medium or 5% ccFCS with R1881 or EGF. 
mented with penicillin and streptomycin. Further additions were made as indicated in 
the legends of Table I and Figure 1. Either 5% FCS or 5 %  steroid-depleted fetal calf 
serum (ccFCS) (obtained by treatment twice with dextran-coated charcoal; charcoal 
1 % , dextran 0.1 %) was added. During the culture period of several weeks, cells were 
only trypsinized when cultures were (nearly) confluent. Medium was changed twice 
a week. Cells were maintained in a humidified atmosphere of 5% CO, in air. 
Androgen Sensitivity 
The LNCaP cells were trypsinized and plated out in 24 multi-well dishes (Fal- 
con, Oxnard, CA) at a density of 2 X lo4 cells/cm2 in RPMI-1640 medium with 5% 
CCFCS medium. Cells were allowed to attach for 2-3 days, after which medium with 
5% ccFCS and a variable concentration of R1881 were added. After 3 days, the media 
were refreshed and, after an additional 3 days, cells were carefully washed with 
phosphate-buffered saline (pH 7.5) and dissolved in 1 M NaOH for determination of 
DNA content [20]. 
PAP and PSA Assays 
The LNCaP cells were cultured as described above for study of androgen 
sensitivity. When the cells were harvested, the conditioned media of the last 3 days 
of culture were sampled, centrifuged, and stored at -20°C. 
The PAP concentration in the media was assayed immunologically with a com- 
mercially available test kit according to the instructions of the supplier (Enzygnost 
PAP; Behring Diagnostica, Frankfurt am Main, Germany). The limit of detection was 
0.2 pg enzyme/L. The antibodies of the kit did not cross-react with other acid 
phosphatase isoenzymes. PAP secretion was expressed as nanograms of PAP per 100 
micrograms of DNA (estimated at the end of the culture period). 
The PSA concentration in the media was measured with an automated micro- 
particle-based enzyme immunoassay (IMx-MEIA; Abbott Diagnostics, Wiesbaden- 
Delkenheim, Germany). Sensitivity of this assay was 0.03 ng/mL, and the inter-assay 
coefficients of variation at 4, 15, and 45 ng/mL were 3.6, 5.8, and 4.6, respectively 
(n = 10). PSA secretion was expressed as nanogram of PSA per microgram of DNA 
(estimated at the end of the culture period). 
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Fig. 1 .  Effects of R1881 on the growth of LNCaP cells. LNCaP cells (A: cells of subline L20; B: cells 
of subline L70) were cultured in the steroid depleted medium (O) ,  in the presence of 0.1 nM R1881 (+), 
or 10 nM R1881 (U). The relative increase in cell mass was calculated from DNA measurements in two 
culture flasks at weekly intervals. 
Nuclear Androgen Receptor Assay 
Androgen receptor concentrations were estimated in LNCaP cells, which were 
cultured for several weeks in different experimental media, as indicated in Table I. 
For the binding assay, the cultures were incubated additionally for 1 hour at 37°C in 
charcoal-treated medium supplemented with 10 nM 3H-R1881. Cells cultured in the 
presence of 10 nM non-radioactive R 188 1 were maintained for 1 week in the presence 
of 10 nM 3H-R1881 (decreased specific activity; 4.3 Ci/mmol) to obtain a complete 
exchange with the radioactive tracer. Thereafter, cells were collected by scraping and 
homogenized by freeze-thawing (three times in liquid nitrogen, followed by thawing 
at 10°C.). Nuclear extracts were prepared and specific binding of 3H-R1881 was 
measured by separation of bound and unbound steroids by protamine precipitation, as 
described previously [21,22]. Non-specific binding of 3H-R1 88 1 in the nuclear ex- 
tracts was less than 5% of the total binding. 
RESULTS 
Growth Studies and Androgen Receptor Levels 
In previous studies, we showed that LNCaP cells proliferated well in medium 
with FCS containing small amounts of endogenous steroids (e.g., 0.1 nM testoster- 
one). When transferred to steroid-depleted medium, maximal growth was obtained 
after the addition of 0.1 nM of the synthetic androgen R1881. It is advantageous to 
use this steroid because the cells rapidly convert dihydrotestosterone, the natural 
ligand of the androgen receptor in prostatic cells [4]. To study possible adaptation 
processes to culture conditions, two androgen sensitive sublines of the LNCaP cell 
line were followed during several weeks in culture, in medium with different andro- 
gen concentrations. Cells of passage 20 (subline L20) and cells of passage 70 (subline 
L70) were compared. In the presence of 10 nM R1881, growth of both cell types was 
initially inhibited, but cells started to proliferate after a lag period of approximately 
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2-3 weeks (Fig. 1). During the lag period, morphological changes were observed: 
Cells lost their epithelial-like structure and rounded up. These changes disappeared 
when cells started to grow. The effect of the increased androgen concentration was 
more pronounced for the L70 cells. For these cultures the addition of 10 nM R1881 
resulted initially in a prominent reduction of total cell number (Fig. 1). In contrast, 
cells cultured in steroid-depleted medium with 0.1 nM R 188 1 continued to grow at a 
constant rate. In steroid-depleted medium without supplements (or supplemented with 
1 nM EGF), the L20 cells did not grow, but remained viable, whereas the L70 cells 
continued to grow at a decreased rate. 
After adaptation of the cells to medium with 10 nM R1881 (at 5 weeks of 
culture), the androgen receptor level in L20 cells showed a limited decrease, while in 
L70 cells the receptor level substantially decreased to approximately 40% of the 
initial value (Table I). A decrease in the amount of androgen receptors to approxi- 
mately 20% was noted in the presence of steroid-depleted medium with EGF. In 
steroid-depleted medium without EGF, receptor levels decreased to a lesser extent 
(250 and 527 fmole/mg protein for L20 and L70 cells, respectively); therefore, the 
addition of EGF contributes to the loss in steroid binding. The effects of different 
culture media on androgen receptor levels were partially reversible: after medium 
change to the original medium with FCS, the concentration of androgen receptors 
increased (Table I: compare line 5 with 7, and 6 with 8; without medium change, 
receptor values remained constant during an additional culture period of 3 weeks). 
Androgen Sensitivity 
Subsequently, the subcultures obtained after 5 weeks of culture under various 
conditions (Table I) were tested for their androgen responsiveness. Three types of 
responses were found: 1) The characteristic biphasic effect of androgens on the 
growth rate was retained by cells cultured in medium with FCS (Fig. 2, L20-FCS and 
L70-FCS) and by cells of the L70 subline cultured in steroid-depleted medium with 
EGF (Fig. 2, L7O-EGF). 2) The cells cultured in medium with increased androgen 
concentration did not show the biphasic effect and were less sensitive to androgens 
(Fig. 2, L20-Andr and L70-Andr). 3 )  Complete loss of response was observed for 
cells of subline L20 after culture in steroid-depleted medium supplemented with EGF 
(Fig. 2, L20-EGF). The reversibility of the effects induced by the different media 
were studied for the L70 subline. Three weeks after change to the original medium 
with FCS, the biphasic dose-response to R1881 was restored (Fig. 3 ) ,  although 
sensitivity to androgens remained less pronounced (compare Figs. 2 and 3 ) .  
Secretion of PAP and PSA 
Secretion of PAP and PSA by the LNCaP cells was studied for the L20 subline. 
An inverse relationship between stimulation of LNCaP cells by R1881 (Fig. 2) and 
secretion of PAP was observed (Fig. 4A: L20-FCS cells). This biphasic effect dis- 
appeared after culture in the presence of 10 nM R1881 for 5 weeks (Fig. 4A: L20- 
Andr cells). These results showed that adaptation of the L20 cells to medium with 
increased androgen concentrations affected not only growth rate, but also PAP se- 
cretion. 
In contrast to the effects of R1881 on cell growth and PAP secretion, no 
biphasic pattern was observed for PSA secretion (Fig. 4B). PSA secretion of all tested 
sublines could be stimulated by concentrations of R1881 up to 10 nM. The absolute 
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Fig. 2. Androgen sensitivity of LNCaP cells adapted to different culture conditions. Cells of subline L20 
and subline L70 were cultured as indicated in Table I for 5 weeks in medium with FCS (subcultures 
L2O-FCS and L70-FCS), in medium with an elevated androgen concentration (subcultures L20-Andr and 
L70-Andr), or in steroid-depleted medium supplemented with EGF (subcultures L2O-EGF and L70-EGF). 
Growth responses of these subcultures to different concentrations of R1881 were estimated as described 
in Materials and Methods in a 6-day test period and were expressed as the relative amount of DNA per 
culture (micrograms of DNA per culture divided by initial value at day zero). Initial values for DNA at 
the start of the 6-day test period were arbitrarily set at 10 (striped bar, abbreviation “ini”). Data are 
expressed as means and SD of four determinations. 
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Fig. 3. Androgen sensitivity after medium change. Cells of subline L70 were adapted either to 10 nM 
R1881 or to steroid-depleted medium with EGF in a 5-week culture period. Subsequently, the cells were 
cultured for 3 weeks in medium with FCS. Abbreviations: L70-Andr-FCS, cells originally adapted to 10 
nM R1881; L70-EGF-FCS, cells originally adapted to 1 nM EGF. Growth response of these subcultures 
to different concentrations of R1881 was estimated as described in Figure 2. 
amount of PSA secretion was lower for the cells adapted to increased androgen 
concentrations (Fig. 4B: L20-Andr cells). We also noted that PSA secretion by 
LNCaP cells was strictly androgen-dependent. EGF-stimulated cell growth was not 
accompanied by a significant secretion of PSA (results not shown). 
DISCUSSION 
In the present study, we showed that large changes in sensitivity to androgens 
of two different sublines (L20 and L70) of the prostate cancer cell line LNCaP could 
be induced within a few weeks under the influence of changes in androgen concen- 
trations in culture media. The L20 subline was derived from a fast-growing colony of 
the original LNCaP cells (LNCaP-FGC) [3]. The L20 subline was androgen-depen- 
dent and did not grow in the absence of steroids. Also, the addition of EGF to the 
steroid-depleted medium did not induce growth within a few weeks. The L70 subline 
was derived from the original L20 line after continuous (routine) culture in medium 
with FCS for more than 1 year. L70 cells lost strict androgen dependence, grew in the 
absence of steroids, and were stimulated by EGF in agreement with previous studies 
[23 ] .  Increase in basal growth rate and loss of steroid sensitivity has been found for 
several mammary carcinoma cell lines [24], e.g., for MCF-7 cells [25], and for 
ZR-75 and T47-D cells [26]. In contrast to these observation for mammary tumor 
cells, the increased basal growth rate of the L70 cells was not accompanied by loss 
of steroid sensitivity. This subline showed increased sensitivity to androgens and 
increased androgen receptor levels. This is not a general phenomenon for LNCaP 
cells, as other sublines have been described with different characteristics and degrees 
of androgen sensitivity [27]. It is not known which factors are involved in changes of 
the different characteristics of these various sublines. 
Both sublines L20 and L70 showed the characteristic biphasic growth response 
to androgens that has also been observed in previous studies with LNCaP cells [7,16]. 
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Fig. 4. PAP and PSA secretion in response to androgens. Cells adapted to medium with FCS or to 
medium with an elevated androgen concentration (subcultures L20-FCS and L20-Andr, see Table I) were 
plated out in dishes with steroid-depleted medium without further supplements. R1881 was added to the 
indicated concentration after 2 days of culture. After an additional 6 days, PAP and PSA concentrations 
were measured in conditioned media of the last 3 days of culture. Values represent the mean of two to four 
determinations. Standard deviation is less than 5%. 
After culture for 5 weeks in the presence of 10 nM of the synthetic androgen R1881 
(a steroid concentration too high to stimulate the L20 and L70 cells at the beginning 
of the culture period), the cells adapted to the increased androgen concentration in the 
medium, and started to proliferate. Androgens no longer exerted a biphasic effect on 
cell proliferation. This effect was partially reversible, as after withdrawal of hormone 
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during 3 weeks, L70 cells regained a biphasic growth response. An inhibitory effect 
of high doses of steroids on growth has been observed for tumor cells transfected with 
an artificially large number of estrogen receptors [28]. These cells are inhibited by 
high concentrations of estrogens, probably due to removal (“squelching”) of an 
essential co-activator during transcription activation [29]. In our studies with LNCaP 
cells, release from the inhibitory effect of high doses of steroids was accompanied by 
a decrease in androgen receptor levels. On the other hand, the changes in steroid 
sensitivity were more pronounced than the changes in receptor level (e.g., for the L20 
cells only a 30% decrease in receptor concentration is seen after adaptation to an- 
drogen-rich medium). In addition, the absolute level of androgen receptors did not 
predict the type of response observed, as L70 cells cultured in steroid-depleted me- 
dium enriched with EGF still showed a biphasic growth response, although androgen 
receptor levels had decreased to 20% of the original value (L70-EGF: Table I and 
Fig. 2). 
The relative large amount of androgen receptors in the original LNCaP cells 
alone is, therefore, not sufficient to explain the biphasic growth curve. One could 
speculate that in cells showing a biphasic growth response, high levels of steroids 
induce a differentiated state of the cells and decrease growth rate. The mechanistic 
basis of differentiation and proliferation is found in the activation of specific sets of 
transcription factors, which regulate the specific genetic programs. Mutual interfer- 
ence between these pathways occurs, as has been shown for several genes regulated 
by both differentiation-inducing members of the steroid hormone receptor family 
(e.g., glucocorticoids) and proliferation-inducing protein products of the f i s  and jun 
genes [30]. In line with the concept that the phenotype of a cell is determined by the 
action of either differentiation or proliferation factors, we observed for a character- 
istic of differentiated cells the secretion of PAP [3 I], with opposite effects of different 
steroid concentrations as for growth rate. The biphasic dose-response curve for PAP 
secretion showed an inverted shape as compared with the growth curve, with minimal 
PAP secretion at the concentration of steroids, inducing the highest growth rate. 
Down-regulation of both PAP production and PAP messenger level by androgens in 
LNCaP cells has also recently been shown in other studies [18,31]. Cells that were 
adapted to an increased concentration of androgens after a culture period of a few 
weeks lost the biphasic response to androgens also with respect to PAP secretion. 
The secretion of PSA, a member of the kallikrein family of serine proteases, is 
another differentiated function of prostatic epithelial cells. PSA secretion could be 
induced by androgens in LNCaP cells, in agreement with other studies [9,18]. How- 
ever, none of the different cell cultures showed an androgen-dependent biphasic 
effect on PSA secretion. Culture in medium with the growth factor EGF stimulated 
cell growth of the L70 subline, but did not induce PSA secretion. A recent study [32] 
showed that prostatic stroma-derived factors exhibited the opposite effect on LNCaP 
cells: decrease in (androgen-induced) growth rate and considerable stimulation of 
both PSA and PAP secretion. 
In conclusion, we have shown that rapid changes of the androgen sensitivity of 
LNCaP cells occur under the influence of increased concentrations of androgens. This 
phenomenon of adaptation to culture conditions is largely reversible, and, therefore, 
is likely due to phenotypic changes of the cells between differentiated and prolifer- 
ative states. The concomitant changes in androgen receptor levels play a limited role 
in this process. 
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It is tempting to extrapolate the results of this study to the situation in the 
patient, and predict that also in vivo androgen-sensitive prostate tumor cells with 
respect to their growth characteristics rapidly and reversibly adapt to changes in 
androgen levels. This effect should be distinguished from a gradual loss of androgen 
sensitivity that occurs during tumor progression. However, additional complexity 
could be expected for a heterogeneous tumor mass growing in close contact with 
several other cells of various tissues. 
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